<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Iranian Journal of Virology</title>
<title_fa>مجله ویروس شناسی ایران</title_fa>
<short_title>Iran J Virol</short_title>
<subject>Medical Sciences</subject>
<web_url>http://journal.isv.org.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>1735-5680</journal_id_issn>
<journal_id_issn_online>2588-5030</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.21859/isv</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1391</year>
	<month>5</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2012</year>
	<month>8</month>
	<day>1</day>
</pubdate>
<volume>6</volume>
<number>3</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Decline of Hepatitis B Virus in Iranian Blood Donors in the Last Decade (2001-2010)</title>
	<subject_fa>عمومى</subject_fa>
	<subject>General</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Original article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>Background and Aims: This study was the trends of Hepatitis B infection among Iranian blood donors which was analyzed in a period of 10 years. Materials and Methods: In a period of 10 years, from 2001 through 2010, a total of 16,264,830 donations from 30 regional and 35 local blood services were screened. All blood samples were tested for Hepatitis B surface antigen (HBs Ag) by commercial available kits. Sistan-Baluchestan (S&amp;B) province representing a high prevalence and Fars province was a low prevalence area. For assessing frequency of infection, the prevalence of HBS Ag per 100 000 donations and 95% confidential intervals (95% CIs) was calculated. Statistical analysis was conducted using chi-square test and considered significant if P value was &lt;0.05. Results: The prevalence rates of HBs Ag dramatically declined from 1.23% in 2001 to 0.25% in 2010 in Iran. In S&amp;B province HBs Ag prevalence decreased from 3.29% in 2001 to 0.66% in 2010 and in Fars province, the rate of HBs Ag decreased from 0.82% in 2001 to 0.12% in 2010. In this period, the number of donation progressively increased from 1361321 donation in 2001 to 1889851 donation in 2010, P v &lt;0.00001. The number of volunteer donations increased from 92% in 2001 to 100% in 2010. Conclusion: The findings indicated that an appropriate implementation of Iranian Blood Transfusion Organization (IBTO) programs such as the selection of blood donors/ donor recruitment, increasing non-remunerated repeat donors, routine screening for blood borne viruses, replacement donation exclusion, and implementation of automation are being performed.</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Hepatitis B virus, Blood Donation, Prevalence, Iranian Blood Transfusion Organization (IBTO)</keyword>
	<start_page>8</start_page>
	<end_page>12</end_page>
	<web_url>http://journal.isv.org.ir/browse.php?a_code=A-10-1-73&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>M</first_name>
	<middle_name></middle_name>
	<last_name>Mahmoodian-Shooshtari </last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846003504</code>
	<orcid>10031947532846003504</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Z</first_name>
	<middle_name></middle_name>
	<last_name>Sharifi  </last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846003505</code>
	<orcid>10031947532846003505</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>SE</first_name>
	<middle_name></middle_name>
	<last_name>Mousavi </last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846003506</code>
	<orcid>10031947532846003506</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>SA</first_name>
	<middle_name></middle_name>
	<last_name>Ahmadi-Teymourloyee  </last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>10031947532846003507</code>
	<orcid>10031947532846003507</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Health Services Management, School of Health Management and Information Sciences, Tehran University of Medical Sciences</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
